About 2018-09-24T14:00:37+00:00

September 24 2018

News

We Need to Do Better – The Search for Opiod Alternatives

July 3rd, 2018|0 Comments

From the news desk of UC San Diego Health: Krishnan Chakravarthy MD, PhD, a pain management specialist at UC San Diego Health and Veterans Affairs San Diego Healthcare System, believes inflammation may be at the [...]

The Chakravarthy Lab website is GDPR compliant

May 26th, 2018|0 Comments

This site (www.chakravarthylab.com) is now GDPR compliant and addressing the requirements of The General Data Protection Regulation (GDPR) (EU) 2016/679. This is a regulation in EU law on data protection and privacy for [...]

Spinal cord stimulation and chronic pain: In the end it’s about the patient

April 28th, 2018|0 Comments

Krishnan Chakravarthy writes in NeuroNews about how spinal cord stimulation can be used to treat chronic pain and how this can help America overcome its opioid epidemic. The statistics are clear, we are amid an [...]

Article – Intrathecal Drug Delivery and Spinal Cord Stimulation for Cancer Pain

April 28th, 2018|0 Comments

Cancer-related pain affects approximately 9 million people worldwide each year, with the number of new cases expected to increase from 12.7 million in 2008 to 22.2 million by 2030.1,2 Cancer pain has been linked to [...]

Dr Krishnan Chakravarthy speaking at Drug Delivery West – San Francisco May 21-22 2018

April 9th, 2018|0 Comments

Dr Krishnan Chakravarthy will be speaking at Drug Delivery West at the Mark Hopkins Intercontinental Hotel in San Francisco in May. About the Event: The PODD teams bring to the West Coast a Drug Delivery [...]

Dr Krishnan Chakravarthy speaking at SBMT 15th Annual Congress – Millennium Biltmore Hotel in LA

March 29th, 2018|0 Comments

Dr Krishnan Chakravarthy will be speaking at the SBMT 15th Annual Congress - Millennium Biltmore Hotel in LA in April. The 15th Annual World Congress of SBMT will bring together physicians, scientists, policy makers, funding [...]

Scientists find new benefit from inhaled anaesthetics to effectively combat lung infections

December 8th, 2017|0 Comments

Lung viral and bacterial infections, like influenza and pneumonia, could be prevented through inhaled anaesthetics commonly used in surgeries, scientists suggest. New experiments have proven that the volatile anaesthetics, nitrous oxide and halothane, have powerful [...]

Anaesthesia may help us fight flu

September 8th, 2017|Comments Off on Anaesthesia may help us fight flu

Certain so-called "volatile" anaesthetics -- commonly used during surgeries -- may also possess powerful effects on the immune system that can combat viral and bacterial infections in the lung, including influenza and pneumonia, say researchers, including one of Indian-origin. [...]

Buffalo nanotech firm ready to grow

September 6th, 2017|0 Comments

A Buffalo nanomaterials firm is hoping a new investment deal will help it accelerate product development and commercialization efforts. NanoAxis LLC is a six-year-old firm that focuses on using nanomaterials for various biomedical applications related [...]

About Chakravarthy Lab

“Right now we absolutely have everything in our hands to revolutionize medicine. I can imagine in 20 years being able to cure all diseases at the genetic level with nanotechnology. It’s mind-boggling. The industry is now at the cutting edge”  Dr Krishnan Chakravarthy

The primary goals of the Chakravarthy Lab are to investigate the pathophysiology and mechanisms of chronic pain in the context of complex regional pain syndrome (CRPS), diabetic neuropathy, persistent postsurgical pain and neuropathic pain.  Further, our lab focuses on how volatile anesthetics and various pain modulators affect host immunity to viral and bacterial infections.

The four core areas of active investigation include:

1. Basic Mechanisms of Chronic Pain

At present we are specifically studying the role of caveolins, inflammatory cytokine mediators (TLR4), and mitochondria in the pathogenesis of chronic pain in settings of complex regional pain syndrome, neuropathic pain, persistent post-operative pain, traumatic brain injury (TBI), and diabetic neuropathy.

 

2. Infectious Diseases

We focus here on the effects of volatile anesthetics toward the mitigation of susceptibility to secondary bacterial pneumonia in post-influenza viral infection: Our laboratory is studying, via a mouse model, the impacts of volatile anesthetics and their ability to down-modulate the type 1 interferon (IFN) response to influenza infection, which results in an increased antibacterial response to secondary bacterial pneumonia.

Based on the deduced mechanisms of how volatile anesthetics function, we are currently working to develop small molecule candidates as alternative vaccine and antibiotic treatments against seasonal and pandemic influenza.

This project is currently being done in conjunction with the US Center for Disease Control.

 

 

 

 

3. Nanomedicine

Currently, our laboratory is working to employ various nanomaterials and biodegradable nanosystems to create novel point of care diagnostics and targeted drug delivery strategies, for the treatment of various chronic pain states, and in infectious disease applications. To these ends we are actively collaborating with the UCSD Department of Nanoengineering.

Our Lab is also working in close collaboration with NanoApps Medical Incorporated, which aims to facilitate and expedite the translation of advanced nanomedical diagnostic, therapeutic, and health monitoring devices and systems (under development) to commercialization on a global scale.

 

 

 

 

 

4. Neuromodulation

The Chakravarthy Lab is also collaborating with the UCSD Integrated Electronics and Bio Interfaces Laboratory to develop new and advanced spinal cord neuromodulation devices for the management of chronic pain.